Ethics and regulatory considerations for the clinical translation of somatic cell human epigenetic editing

Nikolajs Zeps, Tamra Lysaght*, Ruth Chadwick, Alexandre Erler, Roger Foo, Simona Giordano, Poh San Lai, G. Owen Schaefer, Vicki Xafis, Wei Leong Chew, Jeremy Sugarman

*Corresponding author for this work

Research output: Contribution to journalShort surveypeer-review

2 Scopus citations

Abstract

Altering the human epigenome with gene-editing technology in attempt to treat a variety of diseases and conditions seems scientifically feasible. We explore some of the ethical and regulatory issues related to the clinical translation of human epigenetic editing arguing that such approaches should be considered akin to somatic therapies.

Original languageEnglish
Pages (from-to)1652-1655
Number of pages4
JournalStem Cell Reports
Volume16
Issue number7
DOIs
StatePublished - 13 Jul 2021

Fingerprint

Dive into the research topics of 'Ethics and regulatory considerations for the clinical translation of somatic cell human epigenetic editing'. Together they form a unique fingerprint.

Cite this